vsao Journal Nr. 3 - Juni 2022

Perspektiven
Literatur
[1] Lozano R, Naghavi
M, Foreman K, Lim S, Shibuya
K, Aboyans V, et al. Global and
regional mortality from 235 causes
of death for 20 age groups in 1990
and 2010: a systematic analysis for
the Global Burden of Disease Study
2010. Lancet. 2012;380:
2095 – 128.
[2] Skolarikos A, Straub M,
Knoll T, Sarica K, Seitz C, Petřík
A, et al. Metabolic evaluation and
recurrence prevention for urinary
stone patients: EAU guidelines.
Eur Urol. 2015;67:750 – 63.
[3] Pearle MS, Goldfarb
DS, Assimos DG, Curhan G,
Denu-Ciocca CJ, Matlaga BR, et al.
Medical management of kidney
stones: AUA guideline. J Urol.
2014;192:316 – 24.
[4] Abu-Ghanem Y, Shvero
A, Kleinmann N, Winkler HZ, Zilberman
DE. 24-h urine metabolic
profile: is it necessary in all kidney
stone formers? Int Urol Nephrol.
2018;50:1243 – 7.
[5] Goldfarb DS. Empiric
therapy for kidney stones. Urolithiasis.
2019;47:107 – 13.
[6] Dhayat NA, Schaller A,
Albano G, Poindexter J, Griffith
C, Pasch A, et al. The Vacuolar
H+-ATPase B1 Subunit Polymorphism
p.E161K Associates with
Impaired Urinary Acidification in
Recurrent Stone Formers. J Am Soc
Nephrol. 2016;27:1544 – 54.
[7] Dhayat NA, Gradwell
MW, Pathare G, Anderegg
M, Schneider L, Luethi D, et al.
Furosemide / Fludrocortisone Test
and Clinical Parameters to Diagnose
Incomplete Distal Renal Tubular Acidosis
in Kidney Stone Formers. Clin
J Am Soc Nephrol. 2017;12:1507 – 17.
[8] Pak CY, Oata M,
Lawrence EC, Snyder W. The hypercalciurias.
Causes, parathyroid
functions, and diagnostic criteria.
J Clin Invest. 1974;54:387 – 400.
[9] Daudon M, Hennequin
C, Boujelben G, Lacour B, Jungers
P. Serial crystalluria determination
and the risk of recurrence in
calcium stone formers. Kidney Int.
2005;67:1934 – 43.
[10] Forni Ogna V, Ogna A,
Vuistiner P, Pruijm M, Ponte B,
Ackermann D, et al. New anthropometry-based
age- and sex-specific
reference values for urinary 24-
hour creatinine excretion based on
the adult Swiss population. BMC
Med. 2015;13:40.
[11] Borghi L, Meschi T,
Amato F, Briganti A, Novarini A,
Giannini A. Urinary volume, water
and recurrences in idiopathic
calcium nephrolithiasis: a 5-year
randomized prospective study. J
Urol. 1996;155:839 – 43.
[12] Curhan GC, Willett WC,
Speizer FE, Stampfer MJ. Twentyfour-hour
urine chemistries and
the risk of kidney stones among
women and men. Kidney Int.
2001;59:2290 – 8.
[13] Milose JC, Kaufman
SR, Hollenbeck BK, Wolf JS Jr.,
Hollingsworth JM. Prevalence
of 24-hour urine collection in
high risk stone formers. J Urol.
2014;191:376 – 80.
[14] Song S, Thomas IC,
Ganesan C, Sohlberg EM, Chertow
GM, Liao JC, et al. Twenty-Four
Hour Urine Testing and Prescriptions
for Urinary Stone
Disease-Related Medications in
Veterans. Clin J Am Soc Nephrol.
2019;14:1773 – 80.
[15] Ferraro PM, Arrabal-Polo
MA, Capasso G, Croppi E, Cupisti
A, Ernandez T, et al. A preliminary
survey of practice patterns across
several European kidney stone centers
and a call for action in developing
shared practice. Urolithiasis.
2019;47:219 – 24.
[16] Ferraro PM, Unwin R,
Bonny O, Gambaro G. Practice
patterns of kidney stone management
across European and
non-European centers: an in-depth
investigation from the European
Renal Stone Network (ERSN). J
Nephrol. 2020 Sep 12. https://doi.
org/10.1007/s40620-020-00854-6
[17] Williams JC Jr., Gambaro
G, Rodgers A, Asplin J, Bonny
O, Costa-Bauzá A, et al. Urine and
stone analysis for the investigation
of the renal stone former: a
consensus conference. Urolithiasis.
2021;49:1 – 16.
[18] Kocvara R, Plasgura
P, Petrík A, Louzenský G,
Bartonícková K, Dvorácek J. A
prospective study of nonmedical
prophylaxis after a first kidney
stone. BJU Int. 1999;84:393 – 8.
[19] Dauw CA, Alruwaily
AF, Bierlein MJ, Asplin JR, Ghani
KR, Wolf JS Jr., et al. Provider
variation in the quality of metabolic
stone management. J Urol.
2015;193:885 – 90.
Anzeige
Wir können Ärztinnen und Ärzten einiges bieten, weil wir sie gut verstehen.
Als mediservice vsao-Mitglied gehören Sie zu einer privilegierten Gruppe:
Sie haben exklusiven Zugang zu einem Online-Stellenvermittlungsportal und
auf eine Online-Agenda mit Seminarangeboten. Als angehender Arzt können
Sie zudem exklusiv an Laufbahn-Kongressen auf höchstem Niveau teilnehmen.
www.mediservice-vsao.ch
48
3/22 vsao /asmac Journal